# Wedgewood Connect, LLC – FDA Untitled Letter, Nov 17, 2023

Source: https://www.keypedia.com/records/untitled_letter/wedgewood-connect-llc/48ee4659-fbc1-4f3a-bac8-182cf65c19f4

> FDA UNTITLED_LETTER for Wedgewood Connect, LLC on November 17, 2023. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: UNTITLED_LETTER
- Company Name: Wedgewood Connect, LLC
- Inspection Date: 2023-11-17
- Product Type: Drugs
- Office Name: Division of Pharmaceutical Quality Operations IV

## Related Documents

- [483 - 2025-07-03](https://www.keypedia.com/records/483/wedgewood-connect-llc/e023f9a9-1a4c-4d5a-916d-94be427d4f19) — date: July 3, 2025
- [483_RESPONSE - 2023-11-17](https://www.keypedia.com/records/483_response/wedgewood-connect-llc/f7331f63-966b-46c2-9139-d427f1e0e9e1) — date: November 17, 2023
- [UNTITLED_LETTER - 2023-11-17](https://www.keypedia.com/records/untitled_letter/wedgewood-connect-llc/db7c4f87-7a7c-444c-9802-45f5228c2f61) — date: November 17, 2023
- [483 - 2023-11-17](https://www.keypedia.com/records/483/wedgewood-connect-llc/7755e859-157d-4b49-b7c9-c10d3e7f9055) — date: November 17, 2023
- [UNTITLED_LETTER - 2023-11-17](https://www.keypedia.com/records/untitled_letter/wedgewood-connect-llc/4dd0f5cd-1c74-4bed-bd83-a0cffca80945) — date: November 17, 2023

## Related Officers

- [Director - Compliance Branch](https://www.keypedia.com/people/lance-m-de-souza/8445cae5-3104-4159-89e9-e07fb7852270)

Company: https://www.keypedia.com/companies/wedgewood-connect-llc/26eedeaf-d44e-48a5-b4c3-8b28c9b361ff

Office: https://www.keypedia.com/offices/division-of-pharmaceutical-quality-operations-iv/a2d2ff91-dc0f-433e-b91f-ca90ff8998b6
